Table 1.
Baseline Demographics and Clinical Features of Treatment and Waitlist Groups (n = 36)
| Treatment (n = 19) |
No treatment (n = 17) |
p | |
|---|---|---|---|
| Age, years | 10;3 (1;3) | 10;3 (1;1) | .91 |
| 8;5–13;7 | 8;3–12;7 | ||
| Gender (female/male) | 1/18 | 2/15 | .52 |
| Diagnosis | .09 | ||
| Autism | 2 | 0 | |
| Asperger | 3 | 7 | |
| PDDNOS | 14 | 10 | |
| Full scale IQ | 100.1 (15.3) | 103.3 (12.9) | .49 |
| 79–133 | 82–126 | ||
| Verbal IQ | 101.3 (16.2) | 109.1(11.1) | .12 |
| 68–123 | 89–130 | ||
| Nonverbal IQ | 98.4 (16.8) | 96.6 (17.9) | .77 |
| 73–132 | 67–125 | ||
| Autism quotient score | 125.7 (19.4) | 138.9 (19.8) | .14 |
| 99–153 | 114–175 | ||
| (n = 10) | (n = 11) | ||
| Social responsiveness scale | 74.9 (21.6) | 80.2 (22.54) | .61 |
| 51–110 | 39–124 | ||
| (n = 9) | (n = 10) | ||
| Co-morbidity | |||
| No co-morbidity | 14 | 14 | .60 |
| ADHD | 4 | 3 | |
| Learning disorder | 1 | 0 |